Spot on EV, relatively low volume since announcement, and the long delays gave everyone that want to be in ample time to get set, so mostly full, hence a few sellers push the price down. Seem to have pushed through them and with more news flow expected this quarter things should tighten up and tick higher.
I am hoping the Quarterly will give a little more commentary re the trials, and an update on when we expect to see the additional data.
Waiting for a nutraceutical deal to be announced now we have safety data. Could be the next catalyst?
Ann: Successful Landmark Study in Paediatric ASD, page-21
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $52.76M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 5.0¢ | $47.84K | 954.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 291484 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 399999 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |